《国际循环》：能否为我们介绍下哪些患者适合应用CCB？
    Myra Klienpeter：在ACCORD试验的强化降压组，更多患者应用了CCB。对于单纯收缩期高血压患者，我倾向于更多应用CCB。目前上市的单片复方制剂中，有很多含有长效CCB氨氯地平，应用这种单片复方制剂的患者能够较快地将血压降下来，有助于血压达标。

    <International Circulation>: Could you extend this on what patients you would prefer to use calcium channel blockers for?
    Dr Myra Klienpeter: In the intensive therapy of the ACCORD trial there was more calcium channel blocker usage.  In those patients with isolated systolic hypertension I tend to use more calcium channel blockers. A lot of the combination medication being brought into the market in which long standing calcium channel blocker amlodipine is added to the drug and those patients  are able to achieve a low blood pressure in a relatively rapid fashion and help them reach their blood pressure goals.